New York, USA – February 23, 2024 – Immuno-oncology therapy, a groundbreaking approach leveraging the body’s immune system to combat cancer, is reshaping the landscape of cancer treatment. However, the intricate interplay between cancer cells and the immune system demands precise and dependable assay systems for comprehensive research and development. Drawing upon the advanced GTOnco™ platform, Creative Biolabs provides a comprehensive suite of Immuno-Oncology assays, spanning in vitro and in vivo studies, aimed at facilitating the discovery of promising I-O therapeutics.
* I-O assays for in vitro study
For in vitro studies, Creative Biolabs offers a range of highly sensitive and customizable I-O assays, enabling researchers to investigate key immunological processes within controlled laboratory settings. These assays encompass various immune cell functional assays, including proliferation assays, cytokine release assays, and immune cell activation assays. Leveraging state-of-the-art technologies, Creative Biolabs ensures the accuracy and reproducibility of results, empowering researchers to unravel the complexities of immune responses against cancer cells.
* I-O assays for in vivo study
For in vivo studies, Creative Biolabs offers robust animal models and related in vivo assays, streamlining the exploration of gene therapy-based I-O products with reduced time and cost. All experiments are conducted by well-trained technicians in a GLP-compliant and IACUC-regulated facility.
“At Creative Biolabs, we stand beside researchers in their pursuit of groundbreaking discoveries in Immuno-Oncology therapy,” said a scientist at the company. “Our innovative assay solutions empower researchers to navigate the intricacies of the tumor-immune microenvironment, thereby facilitating the development of next-generation cancer treatments.”
Driven by a commitment to quality, flexibility, and customer satisfaction, Creative Biolabs collaborates closely with researchers to develop customized assay solutions tailored to their specific research needs. Researchers can depend on the company for cutting-edge assay technologies and expert support throughout the research journey.
For more information about Immuno-Oncology assay solutions at Creative Biolabs, please visit https://www.creative-biolabs.com/gene-therapy.
About Creative Biolabs
Headquartered in New York, US, Creative Biolabs is a global contract research organization (CRO) that provides discovery and assay services for the development of gene therapy-based I-O drugs to advance oncology and immuno-oncology. This company is known for its high-quality and expansive in vitro and in vivo preclinical models. Their aim is to deliver superior scientific solutions and services to accelerate clients’ gene therapy-based I-O drug discovery.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/gene-therapy